Author

Birgitte Rasmussen

OLAMKICEPT (sgp130Fc) DEMONSTRATES TARGET ENGAGEMENT AND INTERLEUKIN-6 PATHWAY INHIBITION ASSOCIATED WITH CLINICAL EFFECTIVENESS IN AN OPEN LABEL TRIAL (FUTURE) IN ACTIVE IBD

Stefan Schreiber, Konrad Aden, Claudio Conrad, Joana P. Bernardes, Johannes Bethge, Florian Tran, Hanna Hoeper, Susanna Nikolaus, Christoph Röcken, Ian Cottingham, Birgitte Rasmussen, Niclas Petri, Georg H Waetzig, Minhun Chen, Philip Rosenstiel

Item 1 - 1 / 1
1